Biogen said on September 11, 2024 that its board increased the size of the board and elected Lloyd B. Minor, M.D. and Sir Menelas (Mene) Pangalos, Ph.D. as directors.

1. 01

   Biogen said on September 11, 2024 that its board increased the size of the board and elected Lloyd B. Minor, M.D. and Sir Menelas (Mene) Pangalos, Ph.D. as directors.

2. 02

   The company said Dr. Minor's appointment takes effect on October 1, 2024, and Prof Sir Pangalos's appointment takes effect on January 1, 2025.

3. 03

   The company said each new director's term expires at the company's 2025 Annual Meeting of Stockholders (2025 Annual Meeting of Stockholders).

4. 04

   Biogen said both directors will receive the annual cash and equity compensation paid to the company's non-employee directors and will enter into an indemnification agreement with the company on the same terms as its other directors.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.